It brings Medisafe’s total raised to date to roughly $55 million.
#Medisafe app take as needed setting series
Sanofi Ventures and Alive Israel HealthTech Fund led Medisafe’s series C funding announced today, with participation from Leumi Partners, Menorah Mivtachim, and Consensus Business Group, as well as previous backers Pitango Ventures, 7Wire Ventures, Merck Ventures, Octopus Ventures, Lool HealthTech, Triventures, and OurCrowd. Medisafe is continuously advancing its technology to meet the dynamic needs of patients managing complex therapies,” Omri Shor said in a press release. “Today’s investment allows Medisafe to expand holistic treatment support for patients to impact behavior change and ultimately outcomes. Over the past eight years, through partnerships with pharma companies including Merck, Medisafe has amassed a database of over 4 billion dosage behaviors informing JITI. While Medisafe directly competes with Walmart’s CareZone, Shop Apotheke’s MyTherapy, TrialCard’s Mango, and Healthprize, it claims to be among the largest medication management platforms in the world, with over 7 million registered users. And the company’s Maestro product provides a summary of patient census, compliance configuration settings, access to program reporting, and integrations with other vendor data. On the backend, Medisafe’s in-app Care Connector enables clinicians to remotely connect with patients if they need additional assistance. Billions of successful medication doses are managed through Medisafe’s platform, preventing more than 500,000 potentially harmful drug-to-drug interactions.” “Through platform, the company delivers average adherence rates by users of 86%, well above industry norms of 50%. “With AI integration, users’ friends and physicians can be alerted if a user has missed doses, when specific steps have not been completed, or when a patient has some kind of challenging event throughout their journey,” a spokesperson told VentureBeat via email. Moreover, the platform can target “rising-risk” patients with analytics and insights based on real-time behavioral assessments, boosting adherence up to 20%. Medisafe can email and text patients to remind them to take their medications on time.
#Medisafe app take as needed setting how to
Learn how to build, scale, and govern low-code programs in a straightforward way that creates success for all this November 9. Powered by Medisafe’s predictive AI engine - Just-in-time-Interventions (JITI) - the app’s content changes as the patient matriculates through therapy and recovery, delivering instructions on how to administer medication, assessing eligibility for financial support programs, and ordering refills, as well as collecting information for providers via surveys. After a patient enters a medication into Medisafe’s smartphone app, the app guides them through a process that entails collecting release forms and helping them through titration schedules. Medisafe employs what it calls “digital drug companions” to ensure medication takers follow through with their prescriptions. In an effort to address this kind of mistake and prevent it from happening in the future, the brothers created Medisafe, which helps manage prescription schedules by leveraging AI and big data. Due to a miscommunication about his medication schedule, their father accidentally took an extra dose of insulin for his diabetes. In 2012, Medisafe cofounders Omri Shor and Rotem Shor faced a family health emergency.
0 kommentar(er)
